The stock of Consort Medical plc (LON:CSRT) hit a new 52-week high and has GBX 1566.46 target or 34.00% above today’s GBX 1169.00 share price. The 6 months bullish chart indicates low risk for the GBX 575.23 million company. The 1-year high was reported on Nov, 3 by Barchart.com. If the GBX 1566.46 price target is reached, the company will be worth GBX 195.58M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. The stock increased 0.34% or GBX 4 on November 3, hitting GBX 1169. About 6,884 shares traded hands. Consort Medical plc (LON:CSRT) has risen 12.51% since April 6, 2016 and is uptrending. It has outperformed by 11.30% the S&P500.
Consort Medical plc (LON:CSRT) Ratings Coverage
Out of 9 analysts covering Consort Medical PLC (LON:CSRT), 5 rate it a “Buy”, 0 “Sell”, while 4 “Hold”. This means 56% are positive. GBX 1300 is the highest target while GBX 933 is the lowest. The GBX 1108.75 average target is -5.15% below today’s (GBX 1169) stock price. Consort Medical PLC has been the topic of 26 analyst reports since August 20, 2015 according to StockzIntelligence Inc. Stifel Nicolaus maintained the shares of CSRT in a report on Monday, February 22 with “Hold” rating. The firm has “Buy” rating given on Thursday, December 3 by Canaccord Genuity. Investec maintained the stock with “Buy” rating in Thursday, December 3 report. The rating was maintained by Canaccord Genuity with “Buy” on Monday, May 23. As per Thursday, June 2, the company rating was maintained by Canaccord Genuity. Cantor Fitzgerald maintained the shares of CSRT in a report on Tuesday, March 29 with “Buy” rating. The firm has “Buy” rating by Canaccord Genuity given on Thursday, June 16. The firm earned “Hold” rating on Thursday, December 3 by N+1 Singer. The firm has “Buy” rating by Panmure Gordon given on Tuesday, January 19. Canaccord Genuity maintained the shares of CSRT in a report on Wednesday, March 16 with “Buy” rating.
Another recent and important Consort Medical plc (LON:CSRT) news was published by Fool.Co.Uk which published an article titled: “Why GlaxoSmithKline plc, Allergy Therapeutics plc and Consort Medical plc are …” on May 18, 2016.
Consort Medical PLC is a contract development and manufacturing organization . The company has a market cap of 575.23 million GBP. The Company’s principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. It has a 36.19 P/E ratio. The Firm operates through two divisions: Bespak and Aesica.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.